Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome

Fig. 4

Survival analysis of de novo AML patients stratified by the expressions of HOXB-AS3. a Overall survival (OS) in the NTUH AML cohort. b Relapse free survival in the NTUH AML cohort. c OS in the AML patients with intermediate-risk cytogenetic changes. d OS in the TCGA AML cohort. The patients in the NTUH AML cohort were stratified by the expressions of transcript cluster: TC17002858.hg.1 on Affymetrix GeneChip® HTA 2.0 arrays

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us